Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease

January 12, 2026 updated by: Joseph Crivelli, University of Alabama at Birmingham

Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease: A Randomized Controlled Trial (CARDIA Ancillary Study)

The true capacity for a healthy diet to improve urinary stone risk factors is not well-defined. The objective of this study is to measure the effect of adopting a healthy dietary pattern on kidney stone disease (KSD) risk. The working hypothesis is that a Dietary Approaches to Stop Hypertension (DASH)-style diet will improve 24-hour urine stone risk parameters. The approach to testing this hypothesis will be to randomize participants with KSD to a standardized DASH-style vs. Western-style diet for one week. The Bionutrition Unit of the Center for Clinical and Translational Science will provide all meals to participants. The rationale for this study is that by measuring the effect of a DASH-style diet on urinary stone risk parameters, a benchmark for future real-world, implementation studies will be established. Based on available evidence, this will be the first controlled diet study to assess the DASH dietary pattern for improving urinary stone risk parameters.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Recruiting
        • University of Alabama at Birmingham
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Birmingham, AL area participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study OR patients of the University of Alabama at Birmingham/Kirklin Clinic
  • Self-reported, documented, and/or prior imaging-based diagnosis of kidney stone disease
  • Age 19-89
  • Any sex
  • Any race
  • Able to provide informed consent
  • Willing to perform 24-hour urine collections
  • Willing to consume meals prepared by Bionutrition Unit
  • No food allergies/intolerance to any of the foods in the study menus
  • Willing to stop for 7 days before and during study: Multivitamins and/or Dietary supplements (including calcium and vitamin C)

Exclusion Criteria:

  • Dialysis
  • Kidney transplant recipient
  • Estimated glomerular filtration rate (eGFR) <60 ml/min/1.73m2 based on historical laboratory measurements
  • Renal tubular acidosis
  • Current use of acetazolamide, topiramate, or zonisamide
  • Primary hyperparathyroidism or history of parathyroidectomy
  • Hyperthyroidism
  • Sarcoidosis
  • Primary hyperoxaluria
  • Cystinuria
  • Nephrotic syndrome
  • Malabsorptive conditions including inflammatory bowel disease or history of malabsorptive surgery (e.g., Roux-en-Y gastric bypass, small bowel resection)
  • Urinary retention requiring catheterization
  • Urinary diversion
  • Pregnancy
  • Breastfeeding
  • Malignancy treated in the past 12 months other than non-melanoma skin cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: DASH-Style Diet
For seven days, participants will consume a diet characterized by higher intake of fruits, vegetables, and low-fat dairy, in addition to whole grains, poultry, fish, and nuts, but smaller amounts of red meat, sweets, and sugar-containing beverages.
Participants will be randomized to a DASH-style diet
Other: Western-Style Diet
For seven days, participants will consume a diet characterized by characterized by higher intake of red meat, sweets, and items containing added sugar, processed starches, and seed oils, in addition to lower intake of fruits, vegetables, and low-fat dairy.
Participants will be randomized to a Western-style diet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference between the two arms in supersaturation of calcium oxalate
Time Frame: Days 6-7 of the assigned intervention
Supersaturation of calcium oxalate is an index reflecting the propensity for the formation and growth of the most common stone type (calcium oxalate), which is calculated using excretion rates including urinary volume, calcium, citrate, and oxalate.
Days 6-7 of the assigned intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference between the two arms in supersaturation of calcium oxalate between the baseline and intervention periods
Time Frame: Days 6-7 of the assigned intervention
This secondary outcome will be calculated using a difference in differences approach.
Days 6-7 of the assigned intervention
Difference between the two arms in supersaturation of uric acid
Time Frame: Days 6-7 of the assigned intervention
Supersaturation of uric acid is an index reflecting the propensity for the formation and growth of uric acid stones.
Days 6-7 of the assigned intervention
Difference between the two arms in supersaturation of calcium phosphate
Time Frame: Days 6-7 of the assigned intervention
Supersaturation of calcium phosphate is an index reflecting the propensity for the formation and growth of calcium phosphate stones.
Days 6-7 of the assigned intervention
Difference between the two arms in urine volume
Time Frame: Days 6-7 of the assigned intervention
Low urine volume is a stone risk factor.
Days 6-7 of the assigned intervention
Difference between the two arms in urine calcium
Time Frame: Days 6-7 of the assigned intervention
High urine calcium is a stone risk factor.
Days 6-7 of the assigned intervention
Difference between the two arms in urine oxalate
Time Frame: Days 6-7 of the assigned intervention
High urine oxalate is a stone risk factor.
Days 6-7 of the assigned intervention
Difference between the two arms in urine citrate
Time Frame: Days 6-7 of the assigned intervention
Low urine citrate is a stone risk factor.
Days 6-7 of the assigned intervention
Difference between the two arms in urine uric acid
Time Frame: Days 6-7 of the assigned intervention
High urine uric acid is a stone risk factor.
Days 6-7 of the assigned intervention
Difference between the two arms in urine pH
Time Frame: Days 6-7 of the assigned intervention
Urine pH can influence stone formation and growth.
Days 6-7 of the assigned intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2025

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Study Registration Dates

First Submitted

January 4, 2024

First Submitted That Met QC Criteria

January 13, 2024

First Posted (Actual)

January 18, 2024

Study Record Updates

Last Update Posted (Actual)

January 13, 2026

Last Update Submitted That Met QC Criteria

January 12, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Kidney Stone

Clinical Trials on DASH-Style Diet

Subscribe